Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.36 (
caspase-1
)
6,285
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the mechanism of increased expression of
caspase-1
in Hippi expressing HeLa and Neuro 2A cells, reported earlier, we report here that
HIPPI
directly interacted with upstream sequence of
caspase-1
gene (-700 to +17, 717 bp). Deletion of this 717 bp sequence and further analysis by electrophoretic mobility shift assay and fluorescence quenching revealed that
HIPPI
interacted with 60 bp (-151 to -92) upstream sequence of
caspase-1
. We also observed by chromatin immunoprecipitation assay that
HIPPI
interacted with the 717 bp sequence in vivo. In luciferase assay, when expression of the reporter gene was driven by either 717 bp or 60 bp
caspase-1
upstream sequences, luciferase activity was increased in GFP-Hippi expressing HeLa cells in comparison to that obtained with parental HeLa cells with the same constructs. Similar result was obtained in Neuro2A cells with 717 bp
caspase-1
upstream sequence. In summary, we showed that
HIPPI
could interact with the putative promoter sequence of
caspase-1
and increased the expression of the downstream gene suggesting that
HIPPI
could act as transcription regulator.
...
PMID:Interaction of HIPPI with putative promoter sequence of caspase-1 in vitro and in vivo. 1717 59
To investigate the mechanism of increased expression of
caspase-1
caused by exogenous Hippi, observed earlier in HeLa and Neuro2A cells, in this work we identified a specific motif AAAGACATG (- 101 to - 93) at the
caspase-1
gene upstream sequence where
HIPPI
could bind. Various mutations in this specific sequence compromised the interaction, showing the specificity of the interactions. In the luciferase reporter assay, when the reporter gene was driven by
caspase-1
gene upstream sequences (- 151 to - 92) with the mutation G to T at position - 98, luciferase activity was decreased significantly in green fluorescent protein-Hippi-expressing HeLa cells in comparison to that obtained with the wild-type
caspase-1
gene 60 bp upstream sequence, indicating the biological significance of such binding. It was observed that the C-terminal 'pseudo' death effector domain of
HIPPI
interacted with the 60 bp (- 151 to - 92) upstream sequence of the
caspase-1
gene containing the motif. We further observed that expression of caspase-8 and caspase-10 was increased in green fluorescent protein-Hippi-expressing HeLa cells. In addition,
HIPPI
interacted in vitro with putative promoter sequences of these genes, containing a similar motif. In summary, we identified a novel function of
HIPPI
; it binds to specific upstream sequences of the
caspase-1
, caspase-8 and caspase-10 genes and alters the expression of the genes. This result showed the motif-specific interaction of
HIPPI
with DNA, and indicates that it could act as transcription regulator.
...
PMID:Interactions of HIPPI, a molecular partner of Huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase-1, caspase-8 and caspase-10 genes. 1762 17
Earlier we have shown that exogenous expression of
HIPPI
, a molecular partner of Huntingtin interacting protein HIP-1, induces apoptosis and increases expression of caspases-1, -8 and -10 in HeLa and Neuro2A cells. The C-terminal pseudo death effector domain of
HIPPI
(pDED-HIPPI) specifically interacts with the putative promoter sequences of these genes. In the present manuscript, we predict from structural modeling of pDED-
HIPPI
that R393 of
HIPPI
is important for such interaction. R393E mutation in pDED-
HIPPI
decreases the interaction with the putative promoter of
caspase-1
in cells. Expression of
caspase-1
is decreased in cells expressing mutant pDED-
HIPPI
in comparison to that observed in cells expressing wild type pDED-
HIPPI
. Using HIP-1 knocked down cells as well as over expressing HIP-1 with mutation at its nuclear localization signal and other deletion mutations, we demonstrate that translocation of
HIPPI
to the nucleus is mediated by HIP-1 for the increased expression of
caspase-1
.
HIPPI
-HIP-1 heterodimer is detected in cytoplasm as well as in the nucleus and is associated with transcription complex in cells. Taking together, we are able to show the importance of R393 of
HIPPI
and the role of
HIPPI
-HIP-1 heterodimer in the transcription regulation of
caspase-1
.
...
PMID:Transcription regulation of caspase-1 by R393 of HIPPI and its molecular partner HIP-1. 1993 60
Earlier we have shown that the proapoptotic protein
HIPPI
(huntingtin interacting protein 1 (HIP1) protein interactor) along with its molecular partner HIP1 could regulate transcription of the
caspase-1
gene. Here we report that RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a new transcriptional target of
HIPPI
.
HIPPI
could bind to the promoter of REST and increased its expression in neuronal as well as non-neuronal cells. Such activation of REST down-regulated expression of REST target genes, such as brain-derived neurotrophic factor (BDNF) or proenkephalin (PENK). The ability of
HIPPI
to activate REST gene transcription was dependent on HIP1, the nuclear transporter of
HIPPI
. Using a Huntington disease cell model, we have demonstrated that feeble interaction of HIP1 with mutant huntingtin protein resulted in increased nuclear accumulation of
HIPPI
and HIP1, leading to higher occupancy of
HIPPI
at the REST promoter, triggering its transcriptional activation and consequent repression of REST target genes. This novel transcription regulatory mechanism of REST by
HIPPI
may contribute to the deregulation of transcription observed in the cell model of Huntington disease.
...
PMID:Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI). 2183 40